sr 95531 has been researched along with muromonab-cd3 in 1 studies
Studies (sr 95531) | Trials (sr 95531) | Recent Studies (post-2010) (sr 95531) | Studies (muromonab-cd3) | Trials (muromonab-cd3) | Recent Studies (post-2010) (muromonab-cd3) |
---|---|---|---|---|---|
610 | 0 | 209 | 85 | 1 | 50 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, W; Ke, JB; Wang, Z; Yang, XL | 1 |
1 other study(ies) available for sr 95531 and muromonab-cd3
Article | Year |
---|---|
Characterization of spontaneous inhibitory postsynaptic currents in cultured rat retinal amacrine cells.
Topics: Amacrine Cells; Animals; Bicuculline; Boron Compounds; Cadmium Chloride; Calcium; Calcium Channel Blockers; Cells, Cultured; Dantrolene; GABA Antagonists; GABA-A Receptor Antagonists; gamma-Aminobutyric Acid; Imidazoles; Inhibitory Postsynaptic Potentials; Inositol 1,4,5-Trisphosphate Receptors; Macrocyclic Compounds; Membrane Potentials; Oxazoles; Pyridazines; Rats; Rats, Sprague-Dawley; Receptors, GABA-A | 2010 |